Kadin M - Search Results

1

High-dose cyclophosphamide, carmustine, and etoposide with autologous transplantation in Hodgkin's disease: a prognostic model for treatment outcomes.

Wheeler C, Eickhoff C, Elias A, Ibrahim J, Ayash L, McCauley M, Mauch P, Schwartz G, Eder JP, Mazanet R, Ferrara J, Rimm IJ, Guinan E, Bierer B, Gilliland G, Churchill WH, Ault K, Parsons S, Antman K, Schnipper L, Tepler I, Gaynes L, Frei E 3rd, Kadin M, Antin J. Wheeler C, et al. Among authors: kadin m. Biol Blood Marrow Transplant. 1997 Jun;3(2):98-106. Biol Blood Marrow Transplant. 1997. PMID: 9267670 Clinical Trial.

2

Primary diffuse large B-cell lymphoma of the mediastinum: outcome following high-dose chemotherapy and autologous hematopoietic cell transplantation.

Sehn LH, Antin JH, Shulman LN, Mauch P, Elias A, Kadin ME, Wheeler C. Sehn LH, et al. Among authors: kadin me. Blood. 1998 Jan 15;91(2):717-23. Blood. 1998. PMID: 9427731 Free article.

3

Phase I trial of an interleukin-2 fusion toxin (DAB486IL-2) in hematologic malignancies: complete response in a patient with Hodgkin's disease refractory to chemotherapy.

Tepler I, Schwartz G, Parker K, Charette J, Kadin ME, Woodworth TG, Schnipper LE. Tepler I, et al. Among authors: kadin me. Cancer. 1994 Feb 15;73(4):1276-85. doi: 10.1002/1097-0142(19940215)73:4<1276::aid-cncr2820730424>3.0.co;2-d. Cancer. 1994. PMID: 8313331 Clinical Trial.

4

Clinical presentation and outcome in lymphocyte-predominant Hodgkin's disease.

Bodis S, Kraus MD, Pinkus G, Silver B, Kadin ME, Canellos GP, Shulman LN, Tarbell NJ, Mauch PM. Bodis S, et al. Among authors: kadin me. J Clin Oncol. 1997 Sep;15(9):3060-6. doi: 10.1200/JCO.1997.15.9.3060. J Clin Oncol. 1997. PMID: 9294468

5

Patterns of presentation of Hodgkin disease. Implications for etiology and pathogenesis.

Mauch PM, Kalish LA, Kadin M, Coleman CN, Osteen R, Hellman S. Mauch PM, et al. Among authors: kadin m. Cancer. 1993 Mar 15;71(6):2062-71. doi: 10.1002/1097-0142(19930315)71:6<2062::aid-cncr2820710622>3.0.co;2-0. Cancer. 1993. PMID: 8443755

6

Epstein-Barr virus in Hodgkin's disease: correlation of risk factors and disease characteristics with molecular evidence of viral infection.

Sleckman BG, Mauch PM, Ambinder RF, Mann R, Pinkus GS, Kadin ME, Sherburne B, Perez-Atayde A, Thior I, Mueller N. Sleckman BG, et al. Among authors: kadin me. Cancer Epidemiol Biomarkers Prev. 1998 Dec;7(12):1117-21. Cancer Epidemiol Biomarkers Prev. 1998. PMID: 9865430

7

Randomized comparison of low-dose involved-field radiotherapy and no radiotherapy for children with Hodgkin's disease who achieve a complete response to chemotherapy.

Nachman JB, Sposto R, Herzog P, Gilchrist GS, Wolden SL, Thomson J, Kadin ME, Pattengale P, Davis PC, Hutchinson RJ, White K; Children's Cancer Group. Nachman JB, et al. J Clin Oncol. 2002 Sep 15;20(18):3765-71. doi: 10.1200/JCO.2002.12.007. J Clin Oncol. 2002. PMID: 12228196 Clinical Trial.

8

Pathology of Hodgkin's disease.

Kadin ME. Kadin ME. Curr Opin Oncol. 1994 Sep;6(5):456-63. doi: 10.1097/00001622-199409000-00002. Curr Opin Oncol. 1994. PMID: 7827147 Review.

9

The t(2;5) chromosomal translocation is not a common feature of primary cutaneous CD30+ lymphoproliferative disorders: comparison with anaplastic large-cell lymphoma of nodal origin.

DeCoteau JF, Butmarc JR, Kinney MC, Kadin ME. DeCoteau JF, et al. Among authors: kadin me. Blood. 1996 Apr 15;87(8):3437-41. Blood. 1996. PMID: 8605362 Free article.

10

Lymphomatoid papulosis, Ki-1+ lymphoma, and primary cutaneous Hodgkin's disease.

Kadin ME. Kadin ME. Semin Dermatol. 1991 Sep;10(3):164-71. Semin Dermatol. 1991. PMID: 1657104 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

358 results

Search Page

Filters